These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7664782)

  • 1. Functional discrepancies between tumor necrosis factor and lymphotoxin alpha explained by trimer stability and distinct receptor interactions.
    Schuchmann M; Hess S; Bufler P; Brakebusch C; Wallach D; Porter A; Riethmüller G; Engelmann H
    Eur J Immunol; 1995 Aug; 25(8):2183-9. PubMed ID: 7664782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.
    Börset M; Medvedev AE; Sundan A; Espevik T
    Cytokine; 1996 Jun; 8(6):430-8. PubMed ID: 8818539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
    Andrews JS; Berger AE; Ware CF
    J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphotoxin acts as an autocrine growth factor for Epstein-Barr virus-transformed B cells and differentiated Burkitt lymphoma cell lines.
    Gibbons DL; Rowe M; Cope AP; Feldmann M; Brennan FM
    Eur J Immunol; 1994 Aug; 24(8):1879-85. PubMed ID: 8056047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors.
    Browning JL; Dougas I; Ngam-ek A; Bourdon PR; Ehrenfels BN; Miatkowski K; Zafari M; Yampaglia AM; Lawton P; Meier W
    J Immunol; 1995 Jan; 154(1):33-46. PubMed ID: 7995952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
    Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
    J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the differing effects of tumor necrosis factor and lymphotoxin on the growth of several human tumor lines.
    Browning J; Ribolini A
    J Immunol; 1989 Sep; 143(6):1859-67. PubMed ID: 2550545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of action of the tumor necrosis factor and lymphotoxin ligand-receptor system.
    Warzocha K; Bienvenu J; Coiffier B; Salles G
    Eur Cytokine Netw; 1995; 6(2):83-96. PubMed ID: 7578992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands.
    Hochman PS; Majeau GR; Mackay F; Browning JL
    J Inflamm; 1995-1996; 46(4):220-34. PubMed ID: 8878796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes.
    Browning JL; Sizing ID; Lawton P; Bourdon PR; Rennert PD; Majeau GR; Ambrose CM; Hession C; Miatkowski K; Griffiths DA; Ngam-ek A; Meier W; Benjamin CD; Hochman PS
    J Immunol; 1997 Oct; 159(7):3288-98. PubMed ID: 9317127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
    Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
    Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signaling through the lymphotoxin-beta receptor stimulates HIV-1 replication alone and in cooperation with soluble or membrane-bound TNF-alpha.
    Marshall WL; Brinkman BM; Ambrose CM; Pesavento PA; Uglialoro AM; Teng E; Finberg RW; Browning JL; Goldfeld AE
    J Immunol; 1999 May; 162(10):6016-23. PubMed ID: 10229841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of TNF ligand and receptor family in the lymphoid organogenesis defined by gene targeting.
    Matsumoto M
    J Med Invest; 1999 Aug; 46(3-4):141-50. PubMed ID: 10687308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine regulation of tumor necrosis factor-alpha and -beta (lymphotoxin)-messenger RNA expression in human peripheral blood mononuclear cells.
    Kasid A; Director EP; Stovroff MC; Lotze MT; Rosenberg SA
    Cancer Res; 1990 Aug; 50(16):5072-6. PubMed ID: 1696166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential activities of secreted lymphotoxin-alpha3 and membrane lymphotoxin-alpha1beta2 in lymphotoxin-induced inflammation: critical role of TNF receptor 1 signaling.
    Sacca R; Cuff CA; Lesslauer W; Ruddle NH
    J Immunol; 1998 Jan; 160(1):485-91. PubMed ID: 9552007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive expression and role of the TNF family ligands in apoptotic killing of tumor cells by human NK cells.
    Kashii Y; Giorda R; Herberman RB; Whiteside TL; Vujanovic NL
    J Immunol; 1999 Nov; 163(10):5358-66. PubMed ID: 10553060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Function, molecular structure and gene expression regulation of tumor necrosis factor and lymphotoxin].
    Higashi N
    Nihon Rinsho; 1992 Aug; 50(8):1939-44. PubMed ID: 1331566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphotoxin lacks effects on 75-kDa receptors in cytotoxicity on U-937 cells.
    Iwamoto S; Shibuya I; Takeda K; Takeda M
    Biochem Biophys Res Commun; 1994 Feb; 199(1):70-7. PubMed ID: 8123048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of 55- and 75-kDa tumor necrosis factor membrane receptors in the regulation of intercellular adhesion molecules-1 expression by HL-60 human promyelocytic leukemia cells in vitro.
    Abe Y; Gatanaga M; Osuka Y; Kimura S; Burger RA; Granger GA; Gatanaga T
    J Immunol; 1993 Jun; 150(11):5070-9. PubMed ID: 8098725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the lymphotoxin beta receptor by cross-linking induces chemokine production and growth arrest in A375 melanoma cells.
    Degli-Esposti MA; Davis-Smith T; Din WS; Smolak PJ; Goodwin RG; Smith CA
    J Immunol; 1997 Feb; 158(4):1756-62. PubMed ID: 9029113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.